Catalyst
Slingshot members are tracking this event:
Amgen (AMGN) set for July 19th PDUFA decision for EVENITY, a treatment for osteoporosis in postmenopausal women
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMGN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 16, 2017
Occurred Source:
http://www.amgen.com/media/news-releases/2017/07/amgen-and-ucb-provide-update-on-regulatory-status-of-evenity-romosozumab-in-the-us/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Postmenopausal, Osteoporosis
